North American Scientific will showcase its ClearPath, a high-dose rate radiation treatment created for breast brachytherapy, aiming to enhance current accelerated partial breast irradiation (APBI) treatment options. The company’s multichannel catheter system, which is inserted through a single incision, is designed to allow for low-dose or high-dose therapy. ClearPath reportedly offers physicians greater flexibility in treatment planning and dose optimization to the target region, while minimizing exposure to nearby healthy tissue.
April 10, 2026 
